Clinical Trials
Green Tea Study:
PHASE IB RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, DOSE ESCALATION STUDY OF POLYPHENON E IN WOMEN WITH A HISTORY OF HORMONE RECEPTOR-NEGATIVE BREAST CANCER
Volunteers between the ages of 21 and 65 are needed to participate in a breast cancer prevention trial looking at whether or not the active ingredient in green tea may be helpful to prevent further problems with breast cancer.
Patient population: * Women who have had a history of stage I, II, or III breast cancer that are cancer free at the time of study entry may be eligible to participate. * Women must have the type of breast cancer that is proven to be estrogen receptor (ER) - negative and progesterone receptor (PR) - negative. * If it has been at least 6 months since your last chemotherapy, radiation or breast surgery you may be eligible for this study. * Normal mammogram on opposite breast within the past 12 months. * Willingness to abstain from drinking tea for 30 days prior to starting the study
Subjects will receive research tests, including mammogram and study drug free of charge.
For more information, call Tawana at 713-798-1994.